Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03634995 · ClinicalTrials.gov registry record · Phase 1
An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 118
- Enrollment target
NCT03634995 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 118 participants.
The verdict
NCT03634995, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 118 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of the experimental medication BMS-986256 in healthy participants.
Interventions
- OTHER Placebo
- DRUG BMS-986256
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2018-08-14 |
| Est. Completion | 2019-10-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03634995
The ClinicalTrials.gov registry entry for NCT03634995 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03634995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03634995 about?
NCT03634995 is a clinical study titled "An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants". The purpose of this study is to evaluate the effects of the experimental medication BMS-986256 in healthy participants.
What is the current status of trial NCT03634995?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2018-08-14. Estimated completion is 2019-10-09.
What interventions are being tested in trial NCT03634995?
The interventions under investigation include: Placebo (OTHER), BMS-986256 (DRUG).
Who is sponsoring clinical trial NCT03634995?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.